Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGaming Realms Regulatory News (GMR)

Share Price Information for Gaming Realms (GMR)

Share Price is delayed by 15 minutes
Get Live Data
32.20    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.90 (2.795%)
Market Cap: £88.12m
GMR Live PriceLast checked at - London Stock Exchange

Intraday Gaming Realms Share Chart

AGM Statement

29 Mar 2010 07:00

RNS Number : 3011J
Pursuit Dynamics PLC
29 March 2010
 



29th March 2010

 

Pursuit Dynamics PLC

("Pursuit" or "the Company" or "PDX")

 

AGM Statement

 

Introduction

 

Since the last Annual General Meeting, Pursuit Dynamics, now operating under the name of PDX, has set a new course under the leadership of Roel Pieper, who was appointed as CEO of the Company in September 2009. After a three month review and planning period, the Company announced with its full year results in November a new organization structure built on the concept of line of business units. These lines of business will be the centres of commercial activity around chosen product market combinations, such as bio fuels, brewing, decontamination and fire suppression solutions.

 

The operational focus of the Company will be driven from two main perspectives:

 

·; The commercialization of existing products and solutions to generate revenue opportunities in the short to medium term that will support the cash flow needs of the Company as best and as early as possible.

·; The creation of new line of business units to ensure that commercial, technical and partnering priorities are properly coordinated in focused business units around a selected product market combination.

 

The management team has recently launched the Brewing line of business and PDX expects to introduce other business lines over the next few months. In addition, the Company have added sales executives for Europe and the USA, as well as key executive management for business development and planning.

 

Energy efficient solutions

 

PDX's mission is to be a leading provider of energy efficient solutions to strategic industrial applications, using the unique patented PDX reactor and atomizing technology to improve output and reduce the use of natural resources.

 

PDX is focused on energy savings and environmental protection and will therefore be selecting new areas of industry where management believes the Company's technologies can make a valuable difference. PDX will continue to look at ways it can develop its technology in a range of sectors, including bio-fuels, alcohol production and waste water to help reduce the use of natural resources. PDX will generate revenues from the savings and benefits that can be delivered to its customers and partners.

 

Finance and Operations

 

The Company has continued to focus on very tight cost control during this period. The various new lines of business are not producing revenues at this stage but the Company can see a much clearer path to those revenues, as well as what will be required to achieve its targets and grow its revenue base going forward. With this in mind, PDX has modestly increased its infrastructure primarily in areas such as sales and marketing and product management, whilst focusing on geographic expansion mainly within the USA and Europe.

 

Corporate Structure and Human Resources

 

PDX intends to develop a commercial basis for operations in all major geographic areas of the global market and it will establish the appropriate corporate structure to support this by region and by line of business.

 

The Company has undertaken a comprehensive review of its global corporate and financial structure and it is currently implementing a series of changes that will efficiently position it for the growth profile it anticipates achieving in the years to come. The intended restructuring does not involve any movement of its R&D focus or registered office from the United Kingdom but it does include establishing new offices in Europe and Asia and a further US office.

 

PDX currently has a team of committed and experienced employees. As it continues with the Company's growth over the course of the year it will direct existing resources into the lines of business and recruit additional resources in line with the requirements of each line of business. The Company is in the process of recruiting executives to lead the bio fuels and brewing lines of business and expects to have those executives on board by the summer.

 

A review of the Company's compensation structure has been undertaken and the objective is to have a structure aligned with the strategic and commercial focus of the whole Company as well as each individual line of business.

 

Research and Development

 

PDX has an existing patent base, which will continue to be developed, focusing on the creation of more application patents built upon its two existing strong atomizer and reactor patents families.

 

The Company will develop its patents to reflect the geographical expansion of the business by ensuring that application patents have a global as well as regional emphasis, optimized for the various regions of the world, protected and leveraged to create the highest returns for the business as a whole.

 

PDX will carefully select which product ideas and scientific developments of the technology could lead to a new solution or even a new line of business. By using this approach, the Company will enable lines of business to make the optimal choices for new opportunities, encouraging innovation and creativity but with the strong discipline of due process and organization.

 

Partnering and Cooperation

 

PDX will continue to work with existing partners and to develop new partnerships and commercial relationships going forward. In all cases the Company will ensure that the PDX brand and value is established as an end-user brand and value. The management team will work with the best possible partners to deliver its ideas and products to market in the most efficient manner. The Company expects the PDX products and solutions to lead to strong revenues both through direct sales to customers and indirectly through royalty and license revenues. There will be continued investment in the Company to ensure that ongoing business creation and R&D can continue to expand the available opportunities.

 

Conclusion

 

PDX is structured to build on a firm foundation of disciplined innovation and creativity underpinned by its patents and technology. These strengths will deliver valuable solutions to various markets and ensure maximum value creation for all stakeholders, whilst providing the financial and commercial discipline that each line of business will need to allow the Company to focus on its global and regional opportunities.

 

The Company and the Board is looking to the future with real enthusiasm and great optimism.

 

- Ends -

 

 

For Further Information, please contact:

Pursuit Dynamics PLC

Roel Pieper, Chief Executive

Donald Bell, Chief Financial Officer

Tel: +44 (0)1480 422050

Financial Dynamics Ben Foster / Marc Cohen

Tel: +44 (0) 20 7831 3113

Cenkos Securities plc

Ian Soanes / Max Hartley

Tel: +44 (0)20 7397 8924

Mirabaud Securities LLP

Rory Scott

Tel: +44 (0) 20 7878 3360

 

 

Notes to Editors

·; Pursuit Dynamics PLC (AIM: PDX) owns and commercialises the PDX fluid processing reactor whose benefits include significant reductions in energy usage, process acceleration and result enhancement for industries such as Bio ethanol production, Food & Drink, Brewing, Fire Suppression and Decontamination.

 

·; Pursuit Dynamics is headquartered in Huntingdon, UK and has an office in Norwalk, Connecticut, USA.

 

·; Further information is available at the Company's website: www.pursuitdynamics.com or www.pdx.biz 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSESFWMFSSEID
Date   Source Headline
4th Apr 20067:00 amPRNGM March Sales
3rd Apr 200612:31 pmPRNRe Agreement
31st Mar 20063:46 pmPRNDelphi Court Motions
29th Mar 20067:00 amPRNGM Annual Report and Accounts
22nd Mar 20067:00 amRNSAcquisition
17th Mar 20067:00 amPRNGM Final Results
15th Mar 20062:12 pmRNSDirector/PDMR Shareholding
8th Mar 20067:03 amRNSDirector/PDMR Shareholding
6th Mar 200611:08 amRNSHolding(s) in Company
6th Mar 20069:00 amPRNGM to Sell Equity Stake in Suzuki
3rd Mar 200610:44 amRNSHolding(s) in Company
2nd Mar 20068:48 amRNSHolding(s) in Company
2nd Mar 20067:00 amPRNGM February Sales
1st Mar 20067:01 amRNSHolding(s) in Company
10th Feb 200610:33 amRNSHolding(s) in Company
7th Feb 20061:47 pmPRNRestructure Proposals
7th Feb 20067:00 amPRNGM Directorate Change
3rd Feb 20064:28 pmRNSHolding(s) in Company
2nd Feb 20067:00 amPRNGM January Sales
1st Feb 200610:14 amRNSDirector/PDMR Shareholding
27th Jan 20067:01 amRNSAGM Statement
26th Jan 20061:37 pmPRNFinal Results
17th Jan 20069:09 amRNSHolding(s) in Company
13th Jan 20062:27 pmPRNResult of Meeting
4th Jan 20067:00 amRNSAdditional Listing
15th Dec 20054:36 pmRNSDirector/PDMR Shareholding
15th Dec 200512:19 pmRNSDirector/PDMR Shareholding
15th Dec 20058:17 amRNSGrant of Global Licence
2nd Dec 20057:05 amPRNGM November Sales
25th Nov 20057:00 amRNS3rd US distributor appointed
16th Nov 20059:20 amRNSHolding(s) in Company
15th Nov 20052:54 pmRNSHolding(s) in Company
11th Nov 20053:41 pmRNSFinal Results
11th Nov 20053:41 pmRNSPlacing
10th Nov 20058:25 amRNSRe Contract
3rd Nov 200510:18 amRNSHolding(s) in Company
2nd Nov 20057:00 amPRNGM October sales
31st Oct 20053:24 pmPRNDividend Declaration
31st Oct 20057:01 amPRNRe Joint Venture
31st Oct 20057:00 amRNSTrading Statement
17th Oct 20051:56 pmPRN3rd Quarter Results
17th Oct 20051:36 pmPRNGM UAW Health Care Agreement
17th Oct 20057:00 amRNSContinental European Licence
11th Oct 200510:06 amRNSFirst Repeat Order Won
6th Oct 200511:02 amRNSAdditional Listing
5th Oct 20051:40 pmPRNDisposal
4th Oct 20056:00 amPRNGM September Sales
3rd Oct 20057:00 amRNSUS Distribution Partner
12th Sep 20059:19 amRNSHolding(s) in Company
5th Sep 20057:00 amRNSFirst US Licence

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.